Literature DB >> 24769326

Relationship of BK polyoma virus (BKV) in the urine with hemorrhagic cystitis and renal function in recipients of T Cell-depleted peripheral blood and cord blood stem cell transplantations.

Yeon Joo Lee1, Junting Zheng2, Yovanna Kolitsopoulos1, Dick Chung1, Isabelle Amigues1, Tammy Son3, Kathleen Choo3, Jeff Hester4, Sergio A Giralt5, Ilya G Glezerman6, Ann A Jakubowski5, Genovefa A Papanicolaou7.   

Abstract

Hematopoietic stem cell transplant (HSCT) recipients are at significant risk for BK virus (BKV) reactivation, hemorrhagic cystitis (HC), and renal dysfunction. We prospectively monitored 98 patients who had received HSCT by serial BKV PCR in the urine through day (D) +100 to analyze the relationship between BK viruria and HC, serum creatinine (Cr), and creatinine clearance (CrCl) through D +180 or death. Patients, median age 52 years (range, 20 to 73), received T cell-depleted (50%) or cord blood allografts (21%). Median pre-HSCT BKV IgG titers were 1:10,240. Incremental increase in BKV IgG titers correlated with developing BK viruria ≥ 10(7) copies/mL. By D +100, 53 (54%) patients had BK viruria. BKV load in the urine increased at engraftment and persisted throughout D +100. HC developed in 10 patients (10%); 7 of 10 with BK viruria. In competing risk analyses, BK viruria ≥ 10(7) copies/mL, older age, cytomegalovirus reactivation, and foscarnet use were risk factors for HC. Cr and CrCl at 2, 3, and 6 months after HSCT were similar between patients with and without BK viruria.
Copyright © 2014 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BK virus; Hematopoietic stem cell transplantation; Hemorrhagic cystitis; Renal function

Mesh:

Year:  2014        PMID: 24769326      PMCID: PMC4099262          DOI: 10.1016/j.bbmt.2014.04.017

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  31 in total

1.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

2.  Keratinocyte growth factor ameliorates cyclophosphamide-induced ulcerative hemorrhagic cystitis.

Authors:  T R Ulich; L Whitcomb; W Tang; P O'Conner Tressel; J Tarpley; E S Yi; D Lacey
Journal:  Cancer Res       Date:  1997-02-01       Impact factor: 12.701

3.  T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies.

Authors:  Ann A Jakubowski; Trudy N Small; Nancy A Kernan; Hugo Castro-Malaspina; Nancy Collins; Guenther Koehne; Katharine C Hsu; Miguel A Perales; Genovefa Papanicolaou; Marcel R M van den Brink; Richard J O'Reilly; James W Young; Esperanza B Papadopoulos
Journal:  Biol Blood Marrow Transplant       Date:  2011-01-11       Impact factor: 5.742

4.  IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade.

Authors:  P A Rowlings; D Przepiorka; J P Klein; R P Gale; J R Passweg; P J Henslee-Downey; J Y Cahn; S Calderwood; A Gratwohl; G Socié; M M Abecasis; K A Sobocinski; M J Zhang; M M Horowitz
Journal:  Br J Haematol       Date:  1997-06       Impact factor: 6.998

5.  Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants.

Authors:  R R Arthur; K V Shah; S J Baust; G W Santos; R Saral
Journal:  N Engl J Med       Date:  1986-07-24       Impact factor: 91.245

6.  Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation.

Authors:  A Y Leung; C K Suen; A K Lie; R H Liang; K Y Yuen; Y L Kwong
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

7.  Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load.

Authors:  Cinthia B Drachenberg; John C Papadimitriou; Hans H Hirsch; Ravinder Wali; Clinton Crowder; Joseph Nogueira; Charles B Cangro; Susan Mendley; Ayesa Mian; Emilio Ramos
Journal:  Am J Transplant       Date:  2004-12       Impact factor: 8.086

8.  Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression.

Authors:  K M Sullivan; H M Shulman; R Storb; P L Weiden; R P Witherspoon; G B McDonald; M M Schubert; K Atkinson; E D Thomas
Journal:  Blood       Date:  1981-02       Impact factor: 22.113

9.  Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation.

Authors:  A Bedi; C B Miller; J L Hanson; S Goodman; R F Ambinder; P Charache; R R Arthur; R J Jones
Journal:  J Clin Oncol       Date:  1995-05       Impact factor: 44.544

10.  Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients.

Authors:  Hans H Hirsch; Wendy Knowles; Michael Dickenmann; Jakob Passweg; Thomas Klimkait; Michael J Mihatsch; Jürg Steiger
Journal:  N Engl J Med       Date:  2002-08-15       Impact factor: 91.245

View more
  8 in total

1.  Antibodies to BK virus in children prior to allogeneic hematopoietic cell transplant.

Authors:  Benjamin L Laskin; Kathleen E Sullivan; Jeff Hester; Jens Goebel; Stella M Davies; Sonata Jodele
Journal:  Pediatr Blood Cancer       Date:  2015-04-01       Impact factor: 3.167

2.  Myeloablative conditioning regimens with combined of haploidentical and cord blood transplantation for myelodysplastic syndrome patients.

Authors:  P Ke; X-B Bao; X-H Hu; J Zhuang; X-J Wu; Y-J Liu; X-F He; D-P Wu; S-L Xue; X Ma
Journal:  Bone Marrow Transplant       Date:  2017-10-30       Impact factor: 5.483

Review 3.  Renal dysfunction following bone marrow transplantation.

Authors:  Stephan Kemmner; Mareike Verbeek; Uwe Heemann
Journal:  J Nephrol       Date:  2016-09-02       Impact factor: 3.902

4.  The Natural History of BK Polyomavirus and the Host Immune Response After Stem Cell Transplantation.

Authors:  Benjamin L Laskin; Michelle R Denburg; Susan L Furth; Taylor Moatz; Michelle Altrich; Steve Kleiboeker; Carolyn Lutzko; Xiang Zhu; Jason T Blackard; Sonata Jodele; Adam Lane; Gregory Wallace; Christopher E Dandoy; Kelly Lake; Alexandra Duell; Bridget Litts; Alix E Seif; Timothy Olson; Nancy Bunin; Stella M Davies
Journal:  Clin Infect Dis       Date:  2020-12-15       Impact factor: 9.079

5.  Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation.

Authors:  Ifigeneia Tzannou; Anastasia Papadopoulou; Swati Naik; Kathryn Leung; Caridad A Martinez; Carlos A Ramos; George Carrum; Ghadir Sasa; Premal Lulla; Ayumi Watanabe; Manik Kuvalekar; Adrian P Gee; Meng-Fen Wu; Hao Liu; Bambi J Grilley; Robert A Krance; Stephen Gottschalk; Malcolm K Brenner; Cliona M Rooney; Helen E Heslop; Ann M Leen; Bilal Omer
Journal:  J Clin Oncol       Date:  2017-08-07       Impact factor: 44.544

Review 6.  BK Polyomavirus-Biology, Genomic Variation and Diagnosis.

Authors:  Jacek Furmaga; Marek Kowalczyk; Tomasz Zapolski; Olga Furmaga; Leszek Krakowski; Grzegorz Rudzki; Andrzej Jaroszyński; Andrzej Jakubczak
Journal:  Viruses       Date:  2021-07-30       Impact factor: 5.048

7.  A Nomogram for Predicting BK Virus Activation in Kidney Transplantation Recipients Using Clinical Risk Factors.

Authors:  Jiyan Wang; Jiawei Li; Zhongli Chen; Ming Xu; Cheng Yang; Ruiming Rong; Tongyu Zhu
Journal:  Front Med (Lausanne)       Date:  2022-02-10

8.  Molecular Epidemiology and Variation of the BK Polyomavirus in the Population of Central and Eastern Europe Based on the Example of Poland.

Authors:  Jacek Furmaga; Marek Kowalczyk; Olga Furmaga; Christos A Rokos; Tomasz Zapolski; Leszek Krakowski; Andrzej Jakubczak; Sławomir Rudzki
Journal:  Viruses       Date:  2022-01-21       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.